3
2
1

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2023-12-16

Yinfeng Low Temperature Medical Technology Co., Ltd. was listed as an innovative small and medium-sized enterprise in Shandong Province in 2022

On December 30, 2022, the Department of Industry and Information Technology of Shandong Province announced the list of innovative small and medium-sized enterprises in Shandong Province for the year 2022, and Yinfeng Low Temperature Medical Technology Co., Ltd. (hereinafter referred to as "Yinfeng Low Temperature") was awarded this honor.

2023-11-30

Pig organs transplanted to monkeys, another new advance in cross-species transplantation

Multiple organs and tissues, including liver, kidney, heart, abdominal wall, cornea, bone, median nerve, etc., from a gene-edited pig were transplanted to seven recipient monkeys. "The study is another useful exploration and positive attempt to find out whether xenotransplantation of tissues and organs is feasible to be applied to emergency treatment of severe tissue destruction and organ failure, which will further expand the feasibility and effectiveness of confirming the application of xenotransplantation to medical rescue." At the media conference held on the 10th, Dou Kefeng, an academician of the Chinese Academy of Sciences, gave a high evaluation of the operation.

2023-11-30

Miracle! Man's thumb was severed for 76 hours, successfully resuscitated

Recently, a banner full of patients' gratitude was sent to the hands of hand and foot surgeons of Qilu Hospital. It turned out that, just more than twenty days ago, Mr. Lu's left thumb was cut off by a machine while he was working at a construction site. The incident was sudden, and the severed finger could not be found during the emergency medical treatment. Two days later, the possibility of being separated from the broken finger and then pick up the living is minimal.

2023-10-26

Heavyweight! Yinfeng Life Continuity Program at the 81st World Science Fiction Convention

On the evening of October 22, the 81st World Science Fiction Convention was successfully closed in Chengdu Science Fiction Museum located in PI District of Chengdu City. During the convention, more than 1,200 guests from 35 countries and regions around the world participated in the meeting, and more than 20,000 fans attended the meeting, and more than 200 themed salons, themed exhibitions, "Hugo Night" lakeside party and other exciting activities were carried out.

2023-10-26

Yinfeng Cryogenics Co-organized and Participated in the 13th National Cryogenic Biomedicine and Instrumentation Annual Conference

October 14-16, 2023, the thirteenth national cryogenic biomedicine and instrumentation academic annual meeting was held in the beautiful coastal city of Qingdao, the annual meeting by the Chinese Refrigeration Society of small refrigerators cryogenic biomedical professional committee, Shanghai Tumor Energy Therapy Technology and Instrumentation Collaborative Innovation Center hosted by Yinfeng cryogenic as a co-sponsor of the depth of participation in which, and on the silver abundance of cryogenic medicine research and transformation aspects of the report in detail.

< 1...262728...46 >
< 1234...28 >